Streetbeat News

Stock Prices

DKNG

Over the past 3 months, 24 Wall Street analysts have provided ratings for DraftKings (NASDAQ:DKNG), with an average price target of $43.04, which is higher than the current price of $38.65. The consensus among these analysts is bullish, with 17 giving a bullish rating and 7 somewhat bullish, while none are indifferent, somewhat bearish, or bearish. The average price target has increased by 13.0% over the past month.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 1:00 pm

BX

Blackstone (NYSE:BX) has experienced a 14.69% increase in short interest since its last report, with 37.08 million shares sold short, representing 5.23% of its float. It would take about 8.37 days to cover all short positions. While an increase in short interest can indicate bearish sentiment, it does not necessarily predict a near-term price decline. Blackstone's short interest is higher than its peer group average of 3.03%.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 1:00 pm

PVH

Over the past 3 months, 13 Wall Street analysts have provided ratings for PVH Corp (NYSE:PVH), with an average price target of $100.54, representing an upside from the current price of $87.09. The consensus among these analysts is leaning towards a bullish outlook with 2 bullish, 7 somewhat bullish, and 4 indifferent ratings. The average price target has seen an 8.69% increase over the past month.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 1:00 pm

MU

Morgan Stanley analyst Joseph Moore has maintained an Underweight rating on Micron Technology (NASDAQ:MU) but increased the price target from $58.5 to $71.5.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 12:58 pm

GSK

GSK plc announced positive Phase 3 trial results for belantamab mafodotin, showing significant improvement in progression-free survival for multiple myeloma compared to the standard of care. Despite previous setbacks with FDA and EMA regulatory issues, the encouraging data could signal a potential comeback for the drug, marketed as Blenrep. GSK shares saw minimal change in premarket trading.

Portfolio Pulse from Vandana Singh

November 27, 2023 | 12:57 pm

LUV

Raymond James analyst Savanthi Syth has maintained an Outperform rating on Southwest Airlines (NYSE:LUV) but lowered the price target from $36 to $34.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 12:54 pm

FSR

LCID

RIVN

TSLA

Needham analyst Chris Pierce reiterated a Buy rating and $25 price target for Rivian (RIVN), keeping it on the firm's 'Conviction List'. He downgraded Lucid (LCID) from Buy to Hold, citing uninspiring Q3 results and tempered expectations for technology licensing to Aston Martin. Pierce also holds Hold ratings on Tesla (TSLA) and Fisker (FSR), expressing concerns over Tesla's margin profile and skepticism about its growth levers. Rivian is seen as an 'underappreciated winner' in the EV transition, being supply-constrained with pricing power and potential for market expansion.

Portfolio Pulse from Shanthi Rexaline

November 27, 2023 | 12:51 pm

CSLR

Complete Solaria, presumably with the ticker CSLR, has announced that its founder, Will Anderson, will continue in his role as Interim CEO. No further details about the duration of his tenure or the reasons for the decision were provided in the article.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 12:32 pm

TRDA

HC Wainwright & Co. analyst Raghuram Selvaraju has maintained a Buy rating on Entrada Therapeutics (NASDAQ:TRDA) but has reduced the price target from $25 to $20.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 12:26 pm

ADI

CHUY

DY

NVDA

Analysts with high accuracy rates have made recent stock picks, with Aaron Rakers of Wells Fargo maintaining an Overweight rating on NVIDIA (NVDA) and raising the target to $675, implying a 41% upside. Matt Bryson of Wedbush reiterated an Outperform rating on NVDA with a $600 target. William Stein of Truist Securities maintained a Buy rating on Analog Devices (ADI) with a reduced target of $206. Brian Mullan of Piper Sandler kept a Neutral rating on Chuy's Holdings (CHUY) with a target of $39. Alex Rygiel of B. Riley Securities maintained a Neutral rating on Dycom Industries (DY) with a target of $101.

Portfolio Pulse from Lisa Levin

November 27, 2023 | 12:07 pm